TSX:GUD (Knight Therapeutics Inc.)
About GUD
Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing innovative pharmaceutical products, consumer health products, and medical devices in Canada and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.
Knight Therapeutics Inc. (TSX: GUD) Latest News
Dividend Stocks
TSX Healthcare in April 2024: The Best Stocks to Buy Right Now
Stocks for Beginners
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
Dividend Stocks
3 Growth Stocks to Invest $1,000 in Right Now
Dividend Stocks
2 Top Pharmaceutical Stocks to Buy on the TSX Today
Investing
4 Biotech Stocks That Could Break Through the Market
Dividend Stocks
3 Biotech Stocks to Buy Before the Down Market Is Over
Investing
This Biotech Stock Could Offer Big Growth – Even During a Recession
Stocks for Beginners
2 Health Care Stocks Could Return at Least 50% in 1 Year
Investing
Can the Healthcare Sector Rebound in 2022?
Investing
Strong Buy Ratings: 2 Healthcare Stocks With More Than 40% Upside
Coronavirus
Forget Trillium Therapeutics Stock (TSX:TRIL): Buy These Pharma Stocks Instead!
Investing
TFSA Investors: 1 Low-Risk Value Stock With Significant Upside
1❯